Neuphoria Therapeutics Inc.
NEUP
$4.12
-$0.25-5.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.65M | 14.21M | 17.04M | 4.34M | 8.08M |
| Total Receivables | 1.80K | 11.90K | 24.60K | 35.60K | 116.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 222.30K | 740.20K | 20.90K | 18.50K | 231.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 78.60K | 77.90K | -- | -- | -- |
| Total Current Assets | 13.95M | 15.04M | 17.09M | 4.40M | 8.43M |
|
|
|||||
| Total Current Assets | 13.95M | 15.04M | 17.09M | 4.40M | 8.43M |
| Net Property, Plant & Equipment | 77.80K | 105.40K | 126.80K | 152.20K | 199.40K |
| Long-term Investments | 8.67M | 8.64M | 8.45M | 8.41M | 8.90M |
| Goodwill | 8.67M | 8.64M | 8.45M | 8.41M | 8.90M |
| Total Other Intangibles | 4.64M | 4.80M | 4.97M | 5.14M | 5.30M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 74.70K | 74.00K | 82.50K |
| Total Assets | 27.34M | 28.59M | 30.71M | 18.17M | 22.92M |
|
|
|||||
| Total Accounts Payable | 1.37M | 1.15M | 745.30K | 1.53M | 1.33M |
| Total Accrued Expenses | 3.60M | 2.88M | 620.60K | 484.50K | 1.10M |
| Short-term Debt | 33.00K | 32.80K | 31.40K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 85.20K | 116.30K | 121.70K | 118.50K | 129.90K |
| Total Finance Division Other Current Liabilities | 32.70K | 35.80K | 33.00K | -- | -- |
| Total Other Current Liabilities | 32.70K | 35.80K | 33.00K | -- | -- |
| Total Current Liabilities | 5.12M | 4.22M | 1.55M | 2.13M | 2.55M |
|
|
|||||
| Total Current Liabilities | 5.12M | 4.22M | 1.55M | 2.13M | 2.55M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 33.00K | 32.80K | 31.40K | -- | -- |
| Capital Leases | -- | -- | 19.30K | 49.80K | 89.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.71M | 5.37M | 3.14M | 2.24M | 3.21M |
| Total Liabilities | 14.83M | 9.59M | 4.72M | 4.42M | 5.85M |
|
|
|||||
| Common Stock & APIC | 203.56M | 200.19M | 199.37M | 198.19M | 198.28M |
| Retained Earnings | -188.25M | -178.35M | -169.46M | -180.73M | -178.78M |
| Treasury Stock & Other | -2.80M | -2.85M | -3.91M | -3.72M | -2.43M |
| Total Common Equity | 12.51M | 19.00M | 26.00M | 13.75M | 17.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.51M | 19.00M | 26.00M | 13.75M | 17.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.51M | 19.00M | 26.00M | 13.75M | 17.07M |
|
|
|||||